CSIMarket
 


Autolus Therapeutics Plc  (AUTL)
Other Ticker:  
 
 

AUTL's Free Cash Flow Growth by Quarter and Year

Autolus Therapeutics Plc's Free Cash Flow results by quarter and year




AUTL Free Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 0.00 0.00 0.00
III Quarter September -8.45 0.00 0.00 0.00
II Quarter June -112.31 -117.86 -19.79 0.00
I Quarter March 0.00 0.00 0.00 0.00
FY   -120.76 -117.86 -19.79 0.00



AUTL Free Cash Flow third quarter 2023 Y/Y Growth Comment
Autolus Therapeutics Plc in the third quarter 2023 recorded free cash outflow of $ -8.45 millions.

According to the results reported in the third quarter 2023, Autolus Therapeutics Plc achieved the best Free Cash Flow growth in Biotechnology & Pharmaceuticals industry. While Autolus Therapeutics Plc' s Free Cash Flow no change of % ranks overall at the positon no. in the third quarter 2023.




AUTL Free Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Autolus Therapeutics Plc's third quarter 2023 Free Cash Flow $ -8.45 millions AUTL's Income Statement
Autolus Therapeutics Plc's third quarter 2022 Free Cash Flow $ 0.00 millions Quarterly AUTL's Income Statement
New: More AUTL's historic Free Cash Flow Growth >>


AUTL Free Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Free Cash Flow third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Free Cash Flow third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Free Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Autolus Therapeutics Plc's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


AUTL's III. Quarter Q/Q Free Cash Flow Comment
Even if Autolus Therapeutics Plc in the III. Quarter 2023 showed free cash outflow of $ -8.45 millions, management point out, that those numbers show improvement in contrast to the -112.31 millions in the second quarter.

Within Biotechnology & Pharmaceuticals industry Autolus Therapeutics Plc achieved highest sequential Free Cash Flow growth. While Autolus Therapeutics Plc's Free Cash Flow growth quarter on quarter, overall rank is .


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


AUTL's III. Quarter Q/Q Free Cash Flow Comment
Despite the fact, that Autolus Therapeutics Plc in the III. Quarter 2023 showed free cash outflow of $ -8.45 millions, it should be mentioned, that this point to recovery compare to the -112.31 millions in the second quarter.

Within Biotechnology & Pharmaceuticals industry Autolus Therapeutics Plc achieved highest sequential Free Cash Flow growth. While Autolus Therapeutics Plc's Free Cash Flow growth quarter on quarter, overall rank is .


Autolus Therapeutics Plc's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
0
12 Months Ending
0
12 Months Ending
0
Cumulative Free Cash Flow 12 Months Ending $ 0.00 $ -101.47 $ 0.00 $ 0.00 $ 0.00
Y / Y Free Cash Flow Growth (TTM) - - - - -
Year on Year Free Cash Flow Growth Overall Ranking # # # # #
Seqeuential Free Cash Flow Change (TTM) - - - - -
Seq. Free Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Free Cash Flow growth Comment
In the Sep 30 2023 period, Autolus Therapeutics Plc's cumulative trailing twelve month Free Cash Flow remained unchanged compare to the same period a year ago.

Autolus Therapeutics Plc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Free Cash Flow growth Comment
In the Sep 30 2023 period, Autolus Therapeutics Plc's cumulative trailing twelve month Free Cash Flow remained unchanged compare to the same period a year ago.

Autolus Therapeutics Plc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Free Cash Flow Growth
Biotechnology & Pharmaceuticals Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
AUTL's Free Cash Flow Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for AUTL's Competitors
Free Cash Flow Growth for Autolus Therapeutics Plc's Suppliers
Free Cash Flow Growth for AUTL's Customers

You may also want to know
AUTL's Annual Growth Rates AUTL's Profitability Ratios AUTL's Asset Turnover Ratio AUTL's Dividend Growth
AUTL's Roe AUTL's Valuation Ratios AUTL's Financial Strength Ratios AUTL's Dividend Payout Ratio
AUTL's Roa AUTL's Inventory Turnover Ratio AUTL's Growth Rates AUTL's Dividend Comparisons



Companies with similar Free Cash Flow no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Sep 30 2023
Abbvie inc -0.37%$ -0.368 millions
Insulet Corporation-1.23%$ -1.235 millions
National Research Corporation-2.32%$ -2.318 millions
Fonar Corporation-2.93%$ -2.929 millions
Viatris Inc -4.02%$ -4.016 millions
Pediatrix Medical Group Inc -4.07%$ -4.071 millions
Repligen Corp-5.16%$ -5.164 millions
Davita Inc -6.95%$ -6.948 millions
Amgen Inc -7.32%$ -7.320 millions
Adapthealth Corp -7.65%$ -7.653 millions
Dexcom Inc -8.19%$ -8.186 millions
Biogen Inc -10.38%$ -10.378 millions
Avantor Inc -10.69%$ -10.685 millions
Amneal Pharmaceuticals Inc -13.02%$ -13.020 millions
Biomarin Pharmaceutical Inc-14.32%$ -14.322 millions
Organon and Co -17.67%$ -17.666 millions
Hca Healthcare Inc -17.91%$ -17.914 millions
Zimmer Biomet Holdings Inc -25.11%$ -25.111 millions
International Stem Cell Corporation-26.19%$ -26.190 millions
Jazz Pharmaceuticals Plc-26.51%$ -26.507 millions
Universal Health Services Inc -26.74%$ -26.740 millions
Brookdale Senior Living Inc -27.96%$ -27.956 millions
Pacific Health Care Organization Inc -29.00%$ -29.004 millions
Option Care Health Inc -29.95%$ -29.952 millions
Iqvia Holdings Inc -32.44%$ -32.445 millions
Abbott Laboratories-32.48%$ -32.482 millions
Bruker Corporation-36.55%$ -36.547 millions
Sotera Health Company-38.26%$ -38.257 millions
Puma Biotechnology Inc -38.50%$ -38.496 millions
Luna Innovations Inc-38.51%$ -38.514 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com